Published March 13, 2022 | Version v1
Dataset Open

Example of KRAS oncogene mutational regression and HLA haplotype characterization in oligo-metastatic colorectal cancer patient (ID: PAT2)

Description

KRAS oncogene mutational regression from primary tumour to lung metastasis (evaluated through TSO500 panel, Illumina Novaseq 6000 platform) and HLA haplotype characterization (through PCR) in a representative oligo-metastatic colorectal cancer patient (ID: PAT2).

Files

PAT 2 - CCF05032022_00002.pdf

Files (3.3 MB)

Name Size Download all
md5:809b4f6b7f94877f455a17d1021d9227
56.6 kB Download
md5:379a735472965de0b2391209156f0803
45.7 kB Download
md5:9c5089ce344a75d7fb5ccb8da122cfdc
3.2 MB Preview Download